Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
18.1M
-
Shares change
-
+461K
-
Total reported value, excl. options
-
$290M
-
Value change
-
+$9.43M
-
Put/Call ratio
-
4.98
-
Number of buys
-
43
-
Number of sells
-
-21
-
Price
-
$16.04
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2017
92 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q3 2017.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.1M shares
of 170M outstanding shares and own 10.62% of the company stock.
Largest 10 shareholders include FMR LLC (6.07M shares), BlackRock Inc. (1.91M shares), VANGUARD GROUP INC (1.66M shares), Capital World Investors (1.45M shares), Ark Investment Management LLC (893K shares), FEDERATED INVESTORS INC /PA/ (779K shares), RENAISSANCE TECHNOLOGIES LLC (613K shares), Artal Group S.A. (550K shares), D. E. Shaw & Co., Inc. (549K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (428K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.